Key facts
- Notable investors include iAccel (Seongnam-si).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Platpharm
- ·The full record, as it builds
Funding rounds
No funding rounds for Platpharm are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Platpharm
Developer of pharmaceutical direct transaction management platforms designed for integrated business operations. The company's platform streamlines the direct trading process between pharmaceutical companies and clients, featuring centralized management of transactions, user authentication, and secure access, enabling the pharmaceutical market to achieve operational efficiency, transparency, and compliance with regulatory standards.
- Sector
- Healthcare
- HQ
- Jeonju, South Korea
- Founded
- 2023
- Employees
- 15
- Website
- platpharm.co.kr/
- Ownership
- Privately Held (backing)
Platpharm doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Platpharm shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Platpharm in its N-PORT filings yet. We sweep new filings monthly.